Roquefort Therapeutics PLC is engaged in pursuing opportunities to acquire medical biotechnology businesses... Show more
Industry Biotechnology
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PBL | 31.89 | 0.08 | +0.26% |
| PGIM Portfolio Ballast ETF | |||
| ICLN | 16.58 | 0.04 | +0.24% |
| iShares Global Clean Energy ETF | |||
| QMOM | 66.79 | 0.12 | +0.17% |
| Alpha Architect US Quantitative Momt ETF | |||
| MAYM | 32.20 | 0.02 | +0.06% |
| FT Vest U.S. Equity Max Buffer ETF - May | |||
| QTR | 35.22 | N/A | N/A |
| Global X NASDAQ 100® Tail Risk ETF | |||
A.I.dvisor indicates that over the last year, ROQAF has been loosely correlated with GNTA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if ROQAF jumps, then GNTA could also see price increases.
| Ticker / NAME | Correlation To ROQAF | 1D Price Change % | ||
|---|---|---|---|---|
| ROQAF | 100% | N/A | ||
| GNTA - ROQAF | 36% Loosely correlated | -2.67% | ||
| CRBP - ROQAF | 22% Poorly correlated | +2.93% | ||
| SVRA - ROQAF | 21% Poorly correlated | -0.62% | ||
| SKYE - ROQAF | 21% Poorly correlated | -1.84% | ||
| SNTI - ROQAF | 6% Poorly correlated | -0.86% | ||
More | ||||